3-carbazol-9-yl-9-[4-(2-carbazol-9-yl-5-cyanophenyl)phenyl]carbazole-2-carbonitrile
C50H29N5 — CID 154958579
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-carbazol-9-yl-9-[4-(2-carbazol-9-yl-5-cyanophenyl)phenyl]carbazole-2-carbonitrile
3-carbazol-9-yl-9-[4-(2-carbazol-9-yl-5-cyanophenyl)phenyl]carbazole-2-carbonitrile (PubChem CID 154958579) has the molecular formula C50H29N5 and a molecular weight of 699.82 g/mol. Its IUPAC name is 3-carbazol-9-yl-9-[4-(2-carbazol-9-yl-5-cyanophenyl)phenyl]carbazole-2-carbonitrile.
Molecular Properties
| Compound Name | 3-carbazol-9-yl-9-[4-(2-carbazol-9-yl-5-cyanophenyl)phenyl]carbazole-2-carbonitrile |
|---|---|
| PubChem CID | 154958579 |
| Molecular Formula | C50H29N5 |
| Molecular Weight | 699.82 g/mol |
| Exact Mass | 699.24 |
| IUPAC Name | 3-carbazol-9-yl-9-[4-(2-carbazol-9-yl-5-cyanophenyl)phenyl]carbazole-2-carbonitrile |
| SMILES | N#Cc1ccc(-n2c3ccccc3c3ccccc32)c(-c2ccc(-n3c4ccccc4c4cc(-n5c6ccccc6c6ccccc65)c(C#N)cc43)cc2)c1 |
| InChI | InChI=1S/C50H29N5/c51-30-32-21-26-48(54-44-17-7-1-11-36(44)37-12-2-8-18-45(37)54)41(27-32)33-22-24-35(25-23-33)53-43-16-6-5-15-40(43)42-29-49(34(31-52)28-50(42)53)55-46-19-9-3-13-38(46)39-14-4-10-20-47(39)55/h1-29H |
| InChIKey | CLRWHNCHJXKVGC-UHFFFAOYSA-N |
| XLogP | 12.39 |
| TPSA | 62.37 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 55 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 699.82 |
| LogP ≤ 5 | 12.39 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 154958579 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.